Strauss David Eric 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Feb 3, 2020
Insider Transaction Report
Form 4
Strauss David Eric
Director, Corporate Controller
Transactions
- Award
Stock Option (right to buy)
2020-01-31+156,000→ 156,000 totalExercise: $1.22Exp: 2030-01-30→ Common Stock (156,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option vest and become exercisable on January 31, 2021, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.